ArticleAnnals of African medicine2026
Diagnostic Gaps and Management Hurdles: Central Venous Catheter-related Infections in an End-stage Renal Disease Patient in Nigeria.
Article in Annals of African medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
abstractVascular access-related infections are a significant cause of morbidity and mortality among patients on maintenance hemodialysis (MHD). In developing countries like Nigeria, the reliance on central venous catheters (CVCs) as a primary vascular access point increases the risk of catheter-related bloodstream infections (CRBSI). This report highlights the clinical management of CRBSI and the systemic constraints faced in resource-limited settings. The index case was a 49-year-old woman with end-stage renal disease (ESRD) secondary to diabetes mellitus, currently on MHD via a CVC, presented with a high-grade fever during a dialysis session. Clinical examination and positive blood cultures drawn from the dialysis tubing confirmed a CRBSI. No other focal source of infection was identified. Microbiological analysis identified the pathogen (consistent with common isolates like Staphylococcus aureus ). The patient was managed with a combination of topical and parenteral antibiotics tailored to the microbiogram. Following initial stabilization and antibiotic therapy, a catheter exchange was performed to eliminate the source of the infection.The patient showed clinical improvement with the resolution of fever and clearance of the bloodstream infection. However, the management process was complicated by significant local constraints, including the inability to monitor serum trough levels for antibiotic dosing, the high cost of specialized medications, and the limited availability of drugs effective against methicillin-resistant S. aureus (MRSA). Catheter-related bloodstream infection remains a formidable complication for hemodialysis patients in Nigeria. While definitive treatment involving targeted antibiotics and catheter exchange is effective, there is an urgent need for improved access to affordable MRSA-active antibiotics and laboratory facilities for therapeutic drug monitoring to optimize patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.